Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18652770rdf:typepubmed:Citationlld:pubmed
pubmed-article:18652770lifeskim:mentionsumls-concept:C0684249lld:lifeskim
pubmed-article:18652770lifeskim:mentionsumls-concept:C0664336lld:lifeskim
pubmed-article:18652770lifeskim:mentionsumls-concept:C0334227lld:lifeskim
pubmed-article:18652770lifeskim:mentionsumls-concept:C2347610lld:lifeskim
pubmed-article:18652770lifeskim:mentionsumls-concept:C0599894lld:lifeskim
pubmed-article:18652770pubmed:issue4lld:pubmed
pubmed-article:18652770pubmed:dateCreated2008-7-25lld:pubmed
pubmed-article:18652770pubmed:abstractTextWe investigated the difference in survivin expression between a multidrug-resistant lung cancer cell line (H460/cDDP) and its parental counterpart (H460) and the influence of siRNA targeting survivin on the chemosensitivity of H460/cDDP. SiRNA targeting survivin was transfected into H460/cDDP cells using a liposome approach. Survivin mRNA and protein expression were significantly higher in H460/cDDP than H460 cells. The median inhibitory concentrations (IC(50)s) for cisplatin and paclitaxol in vitro against H460/cDDP cells were significantly lower in cells treated with survivin-specific siRNA than in control cells. Apoptosis and cleaved caspase-3 expression were analysed using annexin V and Western blotting, respectively, and showed a significant increase in apoptosis after treatment with the chemotherapeutic agents plus specific siRNA. Specific siRNA sensitized H460/cDDP cells to both cisplatin and paclitaxol. Thus, survivin appears to participate in the multidrug resistance mechanism of H460/cDDP cells and siRNA targeting survivin has the potential to increase the sensitivity of drug-resistant cancer cells to anticancer drugs.lld:pubmed
pubmed-article:18652770pubmed:languageenglld:pubmed
pubmed-article:18652770pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18652770pubmed:citationSubsetIMlld:pubmed
pubmed-article:18652770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18652770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18652770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18652770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18652770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18652770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18652770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18652770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18652770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18652770pubmed:statusMEDLINElld:pubmed
pubmed-article:18652770pubmed:issn0300-0605lld:pubmed
pubmed-article:18652770pubmed:authorpubmed-author:ORRS HSHlld:pubmed
pubmed-article:18652770pubmed:authorpubmed-author:WangGGlld:pubmed
pubmed-article:18652770pubmed:authorpubmed-author:YangHHlld:pubmed
pubmed-article:18652770pubmed:authorpubmed-author:WenJJlld:pubmed
pubmed-article:18652770pubmed:authorpubmed-author:ZhangXXlld:pubmed
pubmed-article:18652770pubmed:authorpubmed-author:ZhengBBlld:pubmed
pubmed-article:18652770pubmed:authorpubmed-author:GEEMMlld:pubmed
pubmed-article:18652770pubmed:authorpubmed-author:HuangW-ZWZlld:pubmed
pubmed-article:18652770pubmed:issnTypePrintlld:pubmed
pubmed-article:18652770pubmed:volume36lld:pubmed
pubmed-article:18652770pubmed:ownerNLMlld:pubmed
pubmed-article:18652770pubmed:authorsCompleteYlld:pubmed
pubmed-article:18652770pubmed:pagination734-47lld:pubmed
pubmed-article:18652770pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:18652770pubmed:meshHeadingpubmed-meshheading:18652770...lld:pubmed
pubmed-article:18652770pubmed:meshHeadingpubmed-meshheading:18652770...lld:pubmed
pubmed-article:18652770pubmed:meshHeadingpubmed-meshheading:18652770...lld:pubmed
pubmed-article:18652770pubmed:meshHeadingpubmed-meshheading:18652770...lld:pubmed
pubmed-article:18652770pubmed:meshHeadingpubmed-meshheading:18652770...lld:pubmed
pubmed-article:18652770pubmed:meshHeadingpubmed-meshheading:18652770...lld:pubmed
pubmed-article:18652770pubmed:meshHeadingpubmed-meshheading:18652770...lld:pubmed
pubmed-article:18652770pubmed:meshHeadingpubmed-meshheading:18652770...lld:pubmed
pubmed-article:18652770pubmed:meshHeadingpubmed-meshheading:18652770...lld:pubmed
pubmed-article:18652770pubmed:meshHeadingpubmed-meshheading:18652770...lld:pubmed
pubmed-article:18652770pubmed:meshHeadingpubmed-meshheading:18652770...lld:pubmed
pubmed-article:18652770pubmed:meshHeadingpubmed-meshheading:18652770...lld:pubmed
pubmed-article:18652770pubmed:articleTitleInfluence of SiRNA targeting survivin on chemosensitivity of H460/cDDP lung cancer cells.lld:pubmed
pubmed-article:18652770pubmed:affiliationDepartment of Thoracic Oncology, Cancer Centre, Sun Yat-Sen University, State Key Laboratory of Oncology in Southern China, Guangzhou, PR China.lld:pubmed
pubmed-article:18652770pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18652770pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:332entrezgene:pubmedpubmed-article:18652770lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18652770lld:entrezgene
lhgdn:association:35206lhgdn:found_inpubmed-article:18652770lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18652770lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18652770lld:pubmed